Phase 4
Completed N=384
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
OHSS (Ovarian Hyperstimulation)
Source: ClinicalTrials.gov NCT00627406 ↗
Enrolled (actual)
384
Serious AEs
0.0%
Results posted
Nov 2013
Primary outcomePrimary: Frequency of Moderate to Severe OHSS. — 0; 2; 2; 0 participants
Summary
The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Frequency of Moderate to Severe OHSS. |
0; 2; 2; 0 | — |
| SECONDARY Pregnancy Rate |
17; 15; 37; 36 | — |
Eligibility Criteria
Inclusion Criteria
- Patient complying with the conditions for IVF or ICSI treatment
- Female age over 20 years and under 40 years
- Normal regular cycle and patients with oligomenorrhea
- BMI > 18 and 25 follicles on the day of triggering ovulation
Data sourced from ClinicalTrials.gov (NCT00627406). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.